HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&G picks up The Art of Shaving

This article was originally published in The Rose Sheet

Executive Summary

Acquisition of high-end men's shaving brand The Art of Shaving is in line with Procter & Gamble's strategy "to build the world's premier male grooming company," firm says June 3. Since its founding in 1996 by Eric Malka and Myriam Zaoui, The Art of Shaving has grown from a niche brand with one Manhattan store to "the world's leading premium shaving brand," according to P&G. Along with brand's best-selling presence in prestige department stores such as Nordstrom and Saks Fifth Avenue, P&G gains namesake chain of 36 retail shops. "The Art of Shaving is an excellent strategic match for P&G, building our global leadership in men's grooming and broadening our portfolio to reach high-end male consumers," says Chip Bergh, group president, global male grooming, P&G Beauty & Grooming. P&G's relationship with The Art of Shaving traces back to 2007 launch of co-developed Fusion Chrome Collection, chrome-handled versions of Gillette Fusion power and manual razors (1"The Rose Sheet" Oct. 15, 2007, p. 7). P&G's male grooming portfolio also includes Old Spice and Braun

You may also be interested in...



New Products In Brief

Oral-B: Toothbrush leader's new Oral-B Triumph with SmartGuide "visually helps consumers improve their brushing habits to promote cleaner teeth and healthier gums," according to recent release. FlossAction brushhead and handle embedded with microchips communicate with a wireless display "to signal when you are brushing too hard, when to move to the next quadrant of the mouth, when you have brushed for two minutes and when it is time to replace the brushhead." Procter & Gamble brand notes that the average person spends about 47 seconds brushing his/her teeth - less than half the dentist-recommended two minutes - and that many people brush too hard, which can contribute to early gum recession. "We wanted to take our best technology to the next level," states Paul Warren, dentist and VP-global professional and scientific relations within P&G's oral-care segment. "The Oral-B Triumph has been clinically proven to prevent and reverse gingivitis and to provide outstanding plaque removal. Now we've created the only power toothbrush that addresses one of the most common problems seen by dentists and hygienists - improper brushing habits." The toothbrush retails for $149.99...

Roche Continues To Make The Case For Gantenerumab In Alzheimer’s Disease

The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.

Brinavess' US Review: EU Postmarket Data Unlikely To Save Troubled AFib Drug

Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug;  FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.

UsernamePublicRestriction

Register

RS016207

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel